Peter Jaslow
Peter Jaslow

Peter Jaslow

Of Counsel

jaslowp@ballardspahr.com
Tel 215.864.8737
Fax 215.864.8999
Philadelphia

Peter Jaslow is a corporate and transactional attorney who advises publicly- and privately-held companies in corporate and commercial transactions. He also counsels clients regarding securities matters, including corporate governance, disclosure, and compliance matters. In particular, Mr. Jaslow represents companies in public and private offerings and other capital-raising transactions, merger and acquisition transactions, and a variety of commercial technology transactions. He works with clients across a variety of industries, including the software and technology, life sciences, pharmaceutical, energy, retail, and apparel industries as well as firms in the securities industry, including investment advisers and securities exchanges.

Mr. Jaslow focuses his practice on technology and life sciences companies and transactions, where he assists clients in developing and implementing business and development strategies and completing other major transactions. His representation of companies in intellectual property and technology transactions includes the negotiation and preparation of licensing agreements, software and application development agreements and SaaS and cloud services agreements. He also handles distribution and manufacturing agreements as well as other commercial agreements for life sciences and technology companies.

In addition, Mr. Jaslow routinely assists and advises entrepreneurs and companies in forming, starting and funding businesses. In such matters, Mr. Jaslow counsels clients with regards to entity formation and structuring, negotiating shareholder and operating agreements, capital raising, including crowdfunding initiatives, and other issues affecting start-up companies.

Mr. Jaslow is a member of Ballard Spahr’s Life Sciences and Technology, Mergers and Acquisition/Private Equity, Securities and Intellectual Property Groups.

Representative Matters

Mr. Jaslow represented companies in the following matters:

  • Recro Pharma, Inc., a specialty pharmaceutical company, in its initial public offering of $30 million of common stock
  • NRG Energy, Inc. a publicly-held energy company, in the offering of securities in connection with the acquisition of assets out of bankruptcy for $2.6 billion
  • Two publicly held companies in sophisticated merger transactions, each with values exceeding $1 billion
  • A managed health care company and member of the Fortune 100 in the negotiation and preparation of an agreement for the development and implementation of a patient portal application for affordable care organizations
  • The sale of majority equity stakes of a sports apparel and premier sneaker company and a brain injury rehabilitation clinic to private equity firms
  • A national securities exchange in connection with SEC enforcement actions, compliance matters and rulemaking initiatives
  • Various private acquisition and disposition transactions ranging in size from $5 million to $170 million
  • Represented a publicly traded, national cable company in various contracting matters, including the development of a state-of-the-art email system and various intellectual property licensing and development agreements

Pro Bono Experience

Mr. Jaslow has advised pro bono clients on selecting and forming charitable entities as well as applying for tax-exempt status. In particular, he helped form and actively supports a nonprofit dedicated to reducing the worldwide rate of drowning, especially among minorities. He has also helped pro bono clients negotiate and prepare commercial licensing agreements.

Professional Activities

Association for Corporate Growth

Co-Chair, Securities Regulation Committee, Philadelphia Bar Association

Publications

Co-author, "SEC Priorities: Sustainability, Board Diversity and Cybersecurity Rulemaking," The Legal Intelligencer, October 31, 2016  

Co-author, "SEC Adopts Rules Permitting Forward Incorporation by Reference on Form S-1 and Simplifying Disclosure Requirements for EGCs," Ballard Spahr alert, February 29, 2016

Co-author, "SEC Addresses Rulemaking Mandates on Compensation," The Legal Intelligencer, October 13, 2015

Co-author, "Amendments to Regulation A: Expanding Access to Capital," The Legal Intelligencer, May 5, 2015

Co-author, "Effecting Effective Disclosure: A Look at the SEC's Initiative," The Legal Intelligencer, February 3, 2015

Contributor, "Pennsylvania Corporate Practice and Forms - The Ballard Spahr Manual"

Co-author, "Final SEC Rules Issued Regarding XBRL Interactive Data Formats," Ballard Spahr Securities Alert, February 2009

Co-author, "Web Sites of Public Companies Will Be Affected by New SEC Guidance," Ballard Spahr Securities Alert, August 5, 2008

Speaking Engagements

Panelist, "2016 Securities Litigation and Regulatory Update," Philadelphia Bar Association Securities Regulations Committee and New Jersey Bar Association Securities Law Committee, Philadelphia November 10, 2016

Panelist, "The 7 Tricky Things Your Marketing Team Should Know About IP," Intellectual Property CLE Institute, Greater Philadelphia Chapter, October 5, 2016

Panelist, BFS Group's 2015 Annual Banking Forum, August 3, 2015

"Regulation A+," Philadelphia Bar Association, Securities Regulation Committee, June 2, 2015

Board Memberships

Vice President, Philadelphia Animal Welfare Society (PAWS)

 






George Washington University Law School (J.D. 2006, with high honors)
Notes Editor, George Washington International Law Review; Member, Order of the Coif

Washington University (B.S.C.S. 2003, cum laude)

Pennsylvania

New Jersey